Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...